Total Payments
$23,317
2024 Payments
$656.46
Companies
29
Transactions
190
Medicare Patients
3,607
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$13,429 (57.6%)
Food & Beverage$7,445 (31.9%)
Travel$2,311 (9.9%)
Consulting$111.66 (0.5%)
Education$20.08 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $7,980 | 3 | 34.2% |
| Food and Beverage | $7,445 | 180 | 31.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,400 | 1 | 23.2% |
| Travel and Lodging | $2,311 | 3 | 9.9% |
| Consulting Fee | $111.66 | 1 | 0.5% |
| Entertainment | $48.74 | 1 | 0.2% |
| Education | $20.08 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $10,039 | 21 | $0 (2023) |
| Outset Medical Inc | $7,614 | 5 | $0 (2022) |
| GlaxoSmithKline, LLC. | $899.46 | 11 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $746.42 | 11 | $0 (2022) |
| Travere Therapeutics, Inc. | $570.99 | 8 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $514.97 | 24 | $0 (2024) |
| Amgen Inc. | $347.57 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $309.62 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $299.59 | 15 | $0 (2024) |
| Medtronic, Inc. | $293.70 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $656.46 | 19 | Travere Therapeutics, Inc. ($256.04) |
| 2023 | $1,596 | 26 | GlaxoSmithKline, LLC. ($497.17) |
| 2022 | $8,667 | 30 | Outset Medical Inc ($7,377) |
| 2021 | $1,269 | 19 | Mallinckrodt Hospital Products Inc. ($408.42) |
| 2020 | $4,171 | 20 | Horizon Therapeutics plc ($3,799) |
| 2019 | $6,040 | 31 | Horizon Therapeutics plc ($5,580) |
| 2018 | $461.93 | 24 | Otsuka America Pharmaceutical, Inc. ($77.83) |
| 2017 | $454.82 | 21 | Fresenius USA Marketing, Inc. ($143.50) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/16/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.78 | General |
| 09/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $13.80 | General |
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $213.09 | General |
| 07/10/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $28.17 | General |
| 05/15/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $23.92 | General |
| 04/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/17/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/27/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $116.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/20/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $20.45 | General |
| 10/24/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $124.89 | General |
| 10/18/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $22.60 | General |
| 10/12/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $124.89 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.09 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 725 | 1,949 | $749,780 | $233,715 |
| 2022 | 16 | 729 | 2,637 | $499,193 | $218,443 |
| 2021 | 18 | 1,012 | 5,288 | $722,286 | $316,951 |
| 2020 | 25 | 1,141 | 4,420 | $986,743 | $405,399 |
Total Patients
3,607
Total Services
14,294
Medicare Billing
$1.2M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 134 | 728 | $224,952 | $70,993 | 31.6% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 93 | 236 | $93,456 | $29,689 | 31.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 23 | 118 | $88,972 | $28,578 | 32.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 148 | 177 | $79,827 | $25,259 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 260 | $85,800 | $22,942 | 26.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 19 | 68 | $61,676 | $19,793 | 32.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 125 | 125 | $58,625 | $18,639 | 31.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 212 | $43,672 | $13,663 | 31.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 13 | 25 | $12,800 | $4,160 | 32.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 133 | 730 | $127,750 | $61,708 | 48.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 29 | 147 | $73,500 | $35,168 | 47.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 148 | 181 | $72,400 | $29,387 | 40.6% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Office | 2022 | 18 | 18 | $46,800 | $19,390 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 178 | $38,270 | $17,915 | 46.8% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 29 | 81 | $32,400 | $13,284 | 41.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 90 | 203 | $24,360 | $12,086 | 49.6% |
| 36215 | Insertion of tube into chest or arm artery, each first order branch | Office | 2022 | 13 | 15 | $39,000 | $7,413 | 19.0% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Office | 2022 | 11 | 12 | $14,400 | $7,281 | 50.6% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 26 | 48 | $9,840 | $5,256 | 53.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 37 | 37 | $8,325 | $5,008 | 60.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 24 | $5,160 | $1,870 | 36.2% |
| 75710 | Review by radiologist of arm or leg artery image | Office | 2022 | 11 | 13 | $4,550 | $1,735 | 38.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2022 | 18 | 19 | $1,900 | $834.74 | 43.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2022 | 35 | 860 | $430.00 | $82.13 | 19.1% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2022 | 21 | 34 | $34.00 | $19.31 | 56.8% |
About Dr. Rizwan Moinuddin, DO
Dr. Rizwan Moinuddin, DO is a Nephrology healthcare provider based in Melrose Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275568578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rizwan Moinuddin, DO has received a total of $23,317 in payments from pharmaceutical and medical device companies, with $656.46 received in 2024. These payments were reported across 190 transactions from 29 companies. The most common payment nature is "Honoraria" ($7,980).
As a Medicare-enrolled provider, Moinuddin has provided services to 3,607 Medicare beneficiaries, totaling 14,294 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Melrose Park, IL
- Active Since 07/12/2006
- Last Updated 06/05/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1275568578
Products in Payments
- KRYSTEXXA (Biological) $10,171
- ACTHAR (Biological) $918.95
- BENLYSTA (Biological) $759.61
- Velphoro (Drug) $346.13
- Kerendia (Drug) $309.62
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $293.70
- JYNARQUE (Drug) $197.21
- FARXIGA (Drug) $185.00
- Veltassa (Drug) $152.15
- TARPEYO (Drug) $116.81
- LOKELMA (Drug) $114.59
- Parsabiv (Biological) $113.66
- Thiola (Drug) $111.83
- COVERA (Device) $103.53
- AURYXIA (Drug) $91.23
- BPV-Fluency (Device) $84.89
- Renal - Non Product Related (Biological) $74.97
- SAMSCA (Drug) $66.74
- Tavneos (Drug) $62.29
- GATTEX (Drug) $60.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Melrose Park
George Naratadam, D.o, D.O
Nephrology — Payments: $3,850
Nephrology $3,850
Constantine Delis, Do, DO
Nephrology — Payments: $1,627
Nephrology $1,627
Martin Finn, Md, MD
Nephrology — Payments: $1,555
Nephrology $1,555
Dr. Neetha Dhananjaya, M.d, M.D
Nephrology — Payments: $1,278
Nephrology $1,278
David Kracker, Md, MD
Nephrology — Payments: $886.12
Nephrology $886.12
Dr. Rajani Kosuri, M.d, M.D
Nephrology — Payments: $270.02
Nephrology $270.02